Latest Comments

With Melinta Merger, Cempra Lands on Its Feet Despite Regulatory Struggles

With Melinta Merger, Cempra Lands on Its Feet Despite Regulatory Struggles

BMS shifts towards precision medicine

BMS shifts towards precision medicine

pSivida and Alimera enter new phase of collaboration on the longest-acting ocular steroid implant

pSivida and Alimera enter new phase of collaboration on the longest-acting ocular steroid implant

Amgen and Array BioPharma partnership: creating waves in autoimmune disorder market

Amgen and Array BioPharma partnership: creating waves in autoimmune disorder market

Dynavax’s Heplisav-B passes key regulatory hurdle with FDA Advisory Committee endorsement

Dynavax’s Heplisav-B passes key regulatory hurdle with FDA Advisory Committee endorsement

The role of the media in determining health views

The role of the media in determining health views

Fighting obesity: Past and future treatments

Fighting obesity: Past and future treatments

Strong safety and efficacy data position Aerie Pharmaceuticals to submit glaucoma NDA for Roclatan

Strong safety and efficacy data position Aerie Pharmaceuticals to submit glaucoma NDA for Roclatan

Samsung’s move towards pharmaceuticals is paying off

Samsung’s move towards pharmaceuticals is paying off

The NHS hopes that data and the ‘model hospital’ will save it money

The NHS hopes that data and the ‘model hospital’ will save it money

Nestling in: food giant makes its mark on the healthcare industry

Nestling in: food giant makes its mark on the healthcare industry

Samsung Bioepis emerging as strong player in the Autoimmune space

Samsung Bioepis emerging as strong player in the Autoimmune space

EULAR 2017: Considerations after first TNF-failure in RA

EULAR 2017: Considerations after first TNF-failure in RA

The anti-vaccination movement and public health

The anti-vaccination movement and public health

Brexit: new alliance hopes to ensure healthcare stability in an uncertain future

Brexit: new alliance hopes to ensure healthcare stability in an uncertain future

EULAR 2017: Big pharma dives back into the lupus pipeline

EULAR 2017: Big pharma dives back into the lupus pipeline

GSK’s tafenoquine could spell the end for relapsing P. vivax malaria

GSK’s tafenoquine could spell the end for relapsing P. vivax malaria

EULAR 2017: Mixed Expectations on Use of Biosimilars in Rheumatoid Arthritis

EULAR 2017: Mixed Expectations on Use of Biosimilars in Rheumatoid Arthritis

U-turn: life-prolonging breast cancer drug now available on the NHS

U-turn: life-prolonging breast cancer drug now available on the NHS

Understanding the risk of over treatment in Type 2 Diabetes

Understanding the risk of over treatment in Type 2 Diabetes

Loss of exclusivity to limit J&J gain after Zytiga label extension

Loss of exclusivity to limit J&J gain after Zytiga label extension